42 results about "Lactose intolerance" patented technology

The invention discloses purple perilla plant milk rich in strontium element and a preparation process thereof. The purple perilla plant milk is prepared from the following raw materials: shelled purple perilla seeds, shelled flaxseeds, peeled cyperus esculentus, sesame, soybeans, peas and strontium-rich water. The preparation method mainly comprises the following steps: raw material pretreatment, fine wet grinding, filtering and deslagging, high-pressure homogenization and refinement, ultrahigh-temperature instantaneous sterilization and sterile filling. The method ensures the fine taste, stability and safety of the product. The plant milk is rich in strontium element and high-quality plant protein, does not contain lactose and cholesterol, and has the advantages of bone health maintenance, low sensitivity and the like. The problems that casein allergy and lactose intolerance risks exist in traditional animal milk, and existing plant milk is low in protein content, unbalanced in nutrition, dependent on additives and single in function are solved.

The invention discloses bifidobacterium longum B14 with efficient lactose degradation capability and low gas production characteristic and application of the bifidobacterium longum B14, and belongs to the technical field of microorganisms. The preservation number of the bifidobacterium longum B14 is GDMCC No: 67276. The bifidobacterium longum B14 strain provided by the invention can effectively decompose lactose in intestinal tracts, meanwhile, uncomfortable symptoms such as abdominal distension caused by gas production are reduced to the maximum extent, and the technical problem that in the prior art, an efficient lactose degradation strain and the low gas production characteristic are difficult to consider at the same time is successfully solved. The invention provides a core strain resource for developing probiotic products capable of relieving main symptoms of lactose intolerance and remarkably reducing side effects. The strain has a definite application prospect and a remarkable industrial value in development of health care products and medicines.

The invention relates to zero-lactose modified milk for coffee as well as a preparation method and application of the zero-lactose modified milk. The zero-lactose modified milk for coffee is prepared by the following steps: carrying out enzymolysis on pasteurized raw milk by adopting Bonlacta lactase at 40-50 DEG C, and then carrying out sterilization and enzyme deactivation on a dairy product subjected to enzymolysis, so as to obtain the zero-lactose modified milk. The modified milk not only meets the eating requirements of lactose intolerant people, but also is used as a milk base in latte coffee, the coffee fragrance is full and rich, the whole milk feeling is prominent, the fusion degree with coffee is high, and the flavor is clean and natural. Particularly, compared with other milk products and coffee beans, the zero-lactose modified milk and the Italian blended coffee beans are combined and can influence each other to generate a featured latte coffee product, so that a coffee brand is helped to form a featured coffee product, and a unique brand taste is slowly formed; and a favorable contribution is made for popularization of coffee brands.

The invention discloses zero-lactose milk containing galactooligosaccharide and a preparation method of the zero-lactose milk, and belongs to the technical field of dairy products. By means of the synergistic effect of the immobilized lactase and the acerola cherry powder extract, efficient hydrolysis of lactose is achieved, the lactose content is reduced to 0.1-0.5 g / 100 mL, meanwhile, 1.0-2.5 g / 100 mL of galactooligosaccharide is generated, and the lactase is especially suitable for people with lactose intolerance to drink. The preparation method comprises the following steps: pasteurizing the raw milk at 60-65 DEG C for 20-40 minutes, and then cooling; adding 0.01 to 0.3 percent of immobilized lactase and 0.001 to 0.1 percent of acerola cherry powder extract under the condition of 20 to 50 DEG C, and stirring and reacting for 10 to 60 minutes; then heating at the temperature of 80-120 DEG C for 5-20 minutes for enzyme deactivation; performing ultrasonic homogenization (200 to 500W, 20 to 70kHz, 10min), cooling and filling; and finally, carrying out ultrahigh pressure sterilization for 5 minutes at 500 MPa and 28 DEG C to ensure that the product is sterile. The stability and the repeated utilization rate of the enzyme are improved through the immobilized enzyme technology, and due to the addition of the acerola cherry powder extract, the product is endowed with natural oxidation resistance while the lactose is synergistically hydrolyzed.

Fermented milk products can provide multiple benefits. However, it was commonly believed that fermented milk products are not suitable for the administration to canids as e.g. dogs can be intolerant to lactose. The present invention provides fermented milk products for administration to canids.

The application belongs to the technical field of microorganisms, and particularly relates to a Bifidobacterium breve RRJK1316 capable of promoting digestion and application thereof. Bifidobacterium breve The Bifidobacterium breve is named as Bifidobacterium breve (RRJK1316), is preserved in the Guangdong Microbial Culture Collection Center, and has a preservation number of GDMCC No. 64764. The strain has strong acid and bile salt resistance, can effectively resist the influence of gastric juice, and can maintain high activity after passing through the digestive tract. The strain has strong digestion promotion function, and the digestion promotion function is better than that of domperidone 75.0 mu g / mL when the concentration of live bacteria is 6.00*10 8 CFU / mL. Meanwhile, the strain has the function of relieving lactose intolerance, and the beta-galactoside enzyme activity reaches 0.793 U / mL.

The invention discloses a double-gel preparation for relieving lactose intolerance and a preparation method of the double-gel preparation, and belongs to the technical field of dietary nutrition. The double-gel preparation comprises the following components: hydrogel in which beta-galactosidase is embedded and oil gel in which probiotics are embedded, the volume ratio of the hydrogel to the oil gel is (0.2 to 0.8): (0.2 to 0.8). According to the double-gel preparation provided by the invention, synergistic slow release can be realized by adjusting the ratio of water to oil, the activity release rate of beta-galactosidase at the intestinal stage is increased to 50-85%, the release amount of probiotics reaches 5 * 10 < 6 >-10 < 7 > CFU / mL, and the double-gel preparation is remarkably optimized compared with a single gel system. Experiments show that the preparation can quickly relieve lactose intolerance symptoms and improve intestinal flora balance, has both nutrition and functionality, and has wide application potential.

This invention relates to the field of food technology, and in particular to a protein powder that promotes bowel movements. To address the problems of some protein powders with added dietary fiber, such as poor compatibility between dietary fiber and protein, poor solubility, rough texture, and insignificant bowel improvement effects, ultimately leading to constipation, this invention comprises whey protein powder, casein powder, inulin, fructooligosaccharides, psyllium husk powder, soybean lecithin, and β-mannanase. This protein powder offers dual benefits of protein supplementation and intestinal health regulation. It efficiently supplements the protein needed by the human body, improves protein absorption and utilization, and is suitable for individuals with lactose intolerance and weak intestinal function. Simultaneously, through the synergistic effect of prebiotics, dietary fiber, and enzymes, it gently improves constipation symptoms, regulates intestinal flora balance, enhances intestinal peristalsis, and fundamentally protects intestinal health.

The invention relates to pure microalgae cheese. The pure microalgae cheese comprises microalgae milk, an acidifying agent and chymosin, the microalgae milk is pure microalgae milk prepared from microalgae raw materials, wherein protein accounts for 40-60% of the dry weight of cells, grease accounts for 8-16% of the dry weight of the cells, and starch accounts for 20-30% of the dry weight of the cells. The pure microalgae milk is adopted as a raw material to prepare the cheese, exogenous starch, fat or protein is not added, a pure microalgae cheese product which is comparable with traditional cheese in flavor and sensory characteristics can be obtained, and the pure microalgae cheese product is good in processing performance and excellent in storage stability; the technical problems that traditional plant-based cheese must be supplemented with a large amount of exogenous starch, fat or protein to adjust the composition structure of raw materials, and the plant-based cheese has a large gap with animal cheese in the characteristics of taste, stretching, melting property, stability and the like are solved. According to the invention, rich high-protein nutritional products are provided for lactose intolerance, animal protein allergy and vegetarians, and the technical blank of the food type of microalgae cheese is filled. The whole microalgae enters the cheese, so that the flavor level of the cheese is enriched, and the comprehensive health-care function of the cheese product is enhanced.

The present application relates to the technical field of meal replacement powder, and discloses a high-protein satiety meal replacement powder containing rice and pea protein and a preparation method thereof.The meal replacement powder comprises a protein component, dietary fiber, high-quality oil, a sweetener, trace nutrients, a stabilizer and a flavor component; wherein the protein component is a composite protein powder prepared by homogenizing, high-temperature shearing and spray drying of rice protein and pea protein.The present application utilizes the complementary characteristics of amino acids of rice protein and pea protein to achieve balanced nutrition, low allergenicity and easy digestion; the combination of dietary fiber, high-quality oil and composite trace nutrients takes into account high protein, high satiety and comprehensive nutrition; the product is prepared by a segmented mixing process and has good stability, diverse flavors and convenient preparation, and is suitable for people with lactose intolerance, weight control, exercise and other groups, solving the technical problems of low protein content, high allergenicity, nutritional imbalance and strong beany odor of traditional meal replacement powder, and being suitable for industrialized popularization and application.

Engineered Bacteroides thetaiotaomicron (Bt) strains, including deletion mutant strains, and methods of use thereof are provided. Methods of delivering a therapeutic compound to a gut microbiome of a subject include generating an engineered Bacteroides thetaiotaomicron (Bt) strain to overproduce outer membrane vesicles (OMVs); loading a target therapeutic compound into the OMVs; and colonizing the gut microbiome of the subject with the engineered Bt strain. In some embodiments, the subject has at least one of lactose intolerance, phenylketonuria, inflammatory bowel disease, and a chronic intestinal condition.

Provided are lactobacillus delbrueckii subsp. bulgaricus VB183, and a culture apparatus and an application thereof, relating to the field of microorganisms. The accession number of the lactobacillus delbrueckii is CGMCC No. 28204. The lactobacillus delbrueckii of the present invention has advantages such as a high lactose degradation rate, strong beta-galactosidase activity, strong acid and alkali resistance, and strong bile salt resistance, has strong antibacterial ability against common pathogenic bacteria, can be used for relieving lactose intolerance, regulating intestinal flora, and preventing and treating intestinal diseases caused by pathogenic bacteria infection, and has a high application value. The provided lactobacillus delbrueckii subsp. bulgaricus VB183 culture apparatus can be used for batch producing lactobacillus delbrueckii subsp. bulgaricus VB183 fermentation products, which is beneficial for the development of microbial agents, foods, medicines, health care products or feed production apparatuses, and the batch production of commercial products, with a high economic value.

This invention discloses a sterile, high-pressure, high-speed rotary process for breaking down goat milk into smaller molecules, belonging to the field of food processing technology. The process includes the following steps: after pretreatment, pasteurization, and homogenization, the goat milk undergoes ultra-high pressure homogenization. A homogenizing valve cutting component passes through the milk at high pressure and high flow rate, breaking down large molecules into smaller molecules. Hydrophobically modified xanthan gum-gellan gum-chitosan composite lactase microcapsules are prepared and added to the small-molecule goat milk at a mass ratio of 4‰-6‰ for enzymatic hydrolysis. The mixture is then filtered to obtain sterile, low-lactose, small-molecule goat milk. Ultra-high pressure homogenization achieves the downsizing of goat milk, improving its digestibility and absorption. The composite microcapsule encapsulation of lactase enables efficient lactose hydrolysis. Hydrophobic modification of xanthan gum enhances the encapsulation efficiency and operational stability of the microcapsules. This invention provides a continuous and sterile process, ensuring adequate aseptic protection. The resulting product combines easy absorption due to its small molecular size with low lactose content, making it suitable for lactose-intolerant individuals and those with weak digestive systems.

The application relates to the technical field of pharmaceutical preparations, in particular to a loratadine immediate-release tablet based on a co-micronization technology and a preparation method thereof; a pharmaceutical composition comprises a co-micronization compound, the co-micronization compound comprises loratadine and a co-micronization carrier; the application discloses a loratadine immediate-release tablet based on a co-micronization technology and a preparation method thereof, the dissolution rate and stability of the loratadine are improved by adopting the co-micronization technology and a new type of excipient combination; meanwhile, the prepared loratadine immediate-release tablet also has good in-vitro dissolution performance; the loratadine immediate-release tablet prepared by the application reduces impurity growth in the production and storage processes and obviously improves the stability of the drug; the loratadine immediate-release tablet disclosed by the application does not contain lactose in the prescription, so that the side reaction of lactose intolerance can be effectively avoided.

The present application belongs to the technical field of cheese preparation, and particularly relates to a method for preparing freeze-dried infant cheese, which comprises primary ingredient preparation, secondary ingredient preparation, cheese shaping, freeze-drying technology and demolding. The required substances for the primary ingredient preparation include fresh milk, edible bacterial strains and rennet. The required substances for the secondary ingredient preparation include prepared fresh cheese, fruits, trehalose, full-fat milk powder, fructo-oligosaccharides, starch, DHA and nutrients. The present application obtains infant cheese which is rich in edible bacterial strains, high in nutritional ingredients, can convert most of the lactose into lactic acid, reduces the problem of lactose intolerance after the infant consumes the cheese, and meets the eating needs of the infant. Meanwhile, the present application not only enriches the types and hierarchical levels of the taste of the cheese, locks the nutritional ingredients in the cheese product, ensures that the cheese product has good nutritional value, but also guarantees the comprehensiveness and balance of the nutritional substances obtained by the infant after consuming the cheese, ensures the absorption effect, and is suitable for large-scale promotion.

The application discloses high-content soluble protein and gamma-aminobutyric acid quinoa milk and a preparation method thereof, and belongs to the technical field of plant milk. The preparation method of the quinoa milk is as follows: quinoa seeds are subjected to cold plasma treatment, and then subjected to germination treatment to obtain germinated quinoa; the germinated quinoa is dried and crushed to obtain germinated quinoa powder; Bacillus subtilis fermentation liquor is added to the germinated quinoa powder for fermentation to obtain quinoa powder fermentation liquor; the quinoa powder fermentation liquor is dried to obtain fermented quinoa powder; then water is added and uniformly mixed to obtain quinoa mixed slurry. The quinoa mixed slurry is subjected to enzymolysis to obtain an enzymolysis liquor; coconut oil and a stabilizer are added to the enzymolysis liquor, and high-pressure microjet treatment is performed to obtain the quinoa milk. The prepared quinoa milk has high contents of soluble protein and gamma-aminobutyric acid, can be used as a milk substitute, and can solve the problems of lactose intolerance and unbalanced nutrition of plant milk, so that the quinoa milk has a good application prospect and value in the technical field of plant milk.

The dairy industry today faces a problem of providing an alternative to adding sweeteners to fermented milk products in order to achieve the desired sweet taste without the added calories. Furthermore, it would be highly advantageous to establish a method for reducing lactose in fermented milk products to a level which is acceptable for lactose-intolerant consumers. The above problems have been solved by providing mutant Streptococcus thermophilus strains and mutant Lactobacillus delbrueckii subsp. bulgaricus strains that excrete glucose to the milk when the milk is inoculated and fermented with such Streptococcus thermophilus strains and Lactobacillus delbrueckii subsp. bulgaricus strains.Thus, the present invention relates to strains of Streptococcus thermophilus and Lactobacillus delbrueckii subsp. bulgaricus which secrete glucose to the milk substrate during fermentation, as well as to mixed cultures comprising the Streptococcus thermophilus strains and the Lactobacillus delbrueckii subsp. bulgaricus strains, starter cultures comprising the strains and dairy products manufactured with the cultures. The present method also relates to use of the strains for decreasing the lactose content of a fermented food product and for boosting growth of the probiotic BB-12®.

The invention discloses a detection reagent and a detection kit for lactose intolerance judgment and a qualitative judgment method for the lactose content in an excrement sample. The detection reagent is used for detecting an excrement sample to judge whether the excrement sample is a lactose-intolerant sample or not, comprises organic dye and strong-alkali weak-acid salt, presents different colors before and after reacting with lactose, and judges whether the excrement sample is the lactose-intolerant sample or not by reacting the excrement sample with the detection reagent. The detection reagent provided by the invention can be used for directly qualitatively detecting the content of reducing sugar in an excrement sample extracting solution according to different colors presented by a reaction system before and after the reaction of organic dye and lactose, so that whether a sample is a lactose intolerant sample or not can be quickly judged; meanwhile, heavy metal ions and the like are prevented from being used, the experiment safety is improved, and the method is friendly to experimenters.

This invention discloses a method for preparing a water-soluble homogeneous heteropolysaccharide from highland barley and its novel application in promoting the expression of β-galactosidase in the small intestinal mucosa, belonging to the field of polysaccharide preparation and application technology. This invention provides a method for preparing the water-soluble homogeneous heteropolysaccharide HBP-1a from highland barley, involving extraction, alcohol precipitation, decolorization, and deproteinization of highland barley raw materials, followed by separation and purification using anion exchange column chromatography and gel column chromatography. The water-soluble homogeneous heteropolysaccharide HBP-1a was successfully isolated from the highland barley polysaccharide. This invention is the first to discover that the water-soluble homogeneous heteropolysaccharide HBP-1a can effectively promote the expression of β-galactosidase in the small intestinal mucosa and can be used to improve symptoms related to lactose intolerance diarrhea. This invention explores a new use for the water-soluble homogeneous heteropolysaccharide HBP-1a from highland barley, broadening its application fields and possessing broad prospects and market value.

The invention belongs to the technical field of formula food for special medical purposes, and particularly discloses animal and plant peptide-containing formula food suitable for inflammatory bowel diseases and a preparation method of the animal and plant peptide-containing formula food. The nutritional food has the advantages of good flowability and solubility, good nutrient uniformity, high quality, no residue feeling, easy absorption, high safety and the like, and meets the requirements of patients with inflammatory enteritis on nutritional food. The composition has the following specific effects: (1) the composition has a recovery effect on intestinal tracts of mice with enteritis; and (2) the low-FODMAP dietary fiber has the effect of improving intestinal inflammation of enteritis patients. (3) the lactose content is extremely low, so that the milk powder is suitable for people with lactose intolerance to eat, and (4) the milk powder has the effects of regulating the pH value of intestinal tracts of mice and proliferating probiotics.

The present application discloses a plant lactobacillus, a complex probiotic for relieving antibiotic diarrhea and lactose intolerance, and an application. The plant lactobacillus MEMP0029 has been preserved in the China General Microbiological Culture Collection Center on January 8, 2026, and the preservation number is CGMCC No. 37324. The present application obtains a complex probiotic by compounding the plant lactobacillus, lactobacillus rhamnosus and lactobacillus reuteri. The plant lactobacillus MEMP0029 has high lactase production characteristics and excellent probiotic function, can effectively relieve antibiotic associated diarrhea and lactose intolerance diarrhea through multiple pathways such as regulating intestinal flora, repairing intestinal barrier, improving lactase activity and inhibiting intestinal inflammation, and has extremely high development and application value.

The invention belongs to the technical field of bioengineering, and particularly relates to kluyveromyces marxianus with high lactase activity as well as a preparation method and application of the kluyveromyces marxianus. According to the method, the kluyveromyces marxianus Fim-3 is subjected to fed-batch fermentation, high expression of lactase is induced, and meanwhile fermentation liquor of high-density thalli is obtained; performing solid-liquid separation on the fermentation liquor to obtain fresh bacterial sludge, and drying to obtain high-activity kluyveromyces marxianus dry yeast; the preparation process comprises the steps of strain activation, seed liquid preparation, fermentation tank culture, lactase induced expression, yeast mud collection and drying and the like, and a seed liquid culture medium, a fermentation liquid culture medium and an induction culture medium are specially prepared; according to the kluyveromyces marxianus provided by the invention, the viable count is 2-4 * 10 < 10 > CFU / g, the lactase content reaches 1000U / g or above, and the maximum degradation rate of lactose in simulated gastrointestinal fluid reaches 99.2%; the compound can be used as a food ingredient for improving the problem of lactose intolerance, and can be used for preparing probiotic products or fermented yoghurt and the like.

The invention belongs to the technical field of microorganisms, and particularly relates to bifidobacterium breve RRJK1316 capable of promoting digestion and application of the bifidobacterium breve RRJK1316. The bifidobacterium breve is named as bifidobacterium breve (Bifidobacterium breve) RRJK1316, the bifidobacterium breve is preserved in the Guangdong Microbial Culture Collection Center, and the preservation number of the bifidobacterium breve is GDMCC (Guangdong Microbial Culture Collection Center) No.64764. The strain has relatively strong acid and cholate resistance, can effectively resist the influence of gastric juice, and can still maintain relatively high activity after passing through the digestive tract. The strain has a relatively strong digestion promoting function, and the digestion promoting function is superior to the action concentration of 75.0 mu g / mL of domperidone when the viable cell concentration is 6.00 * 10 < 8 > CFU / mL. Meanwhile, the beta-galactosidase has the function of relieving lactose intolerance, and the enzyme activity of the beta-galactosidase reaches 0.793 U / mL.

The present invention belongs to the field of fermentation, and specifically relates to a Kluyveromyces marxianus strain, a microbial agent, a fermentation broth, a fermented food, and a preparation and a use thereof. Provided is Kluyveromyces marxianus AMCC 31586, having the accession number CCTCC NO:M20231793. In one aspect, Kluyveromyces marxianus AMCC 31586 has good substrate utilization ability, being able to fully utilize carbon source substrates such as lactose and galactose, thereby reducing the health burden of people with lactose intolerance or galactosemia. In another aspect, fermented milk obtained by fermentation with Kluyveromyces marxianus AMCC 31586 contains unique flavor substances such as eugenol and anethole, and it also has good utilization ability for carbon source substrates such as organic acids, lactose and galactose. Furthermore, in dairy fermentation, it can improve the quality of fermented dairy products and enrich the flavor of fermented dairy products.

The invention provides lutein Chinese wolfberry probiotic yoghurt and a preparation method and application thereof, and relates to the technical field of yoghurt, the lutein Chinese wolfberry probiotic yoghurt is prepared from the following raw materials in percentage by mass: 2-10% of Chinese wolfberry, 0.1-0.9% of lutein, 2-10% of white sugar, 0.02-0.06% of a leavening agent and the balance of fresh milk, the lutein provides a growth-promoting microenvironment for probiotics and enhances the probiotic function expression of the probiotics; meanwhile, xanthophyll and lycium barbarum polysaccharide form a synergistic interaction mechanism, the water-holding capacity and physical stability of the product are remarkably improved, on the other hand, by optimizing the proportion of lycium barbarum and white granulated sugar, proliferation of lactic acid bacteria in the fermentation period is promoted, the stability in the storage period is prolonged, lactose intolerance symptoms are relieved in an auxiliary mode, and the intestinal microecological regulation function is strengthened; the flavor and texture characteristics of the product are improved; the lutein Chinese wolfberry probiotic yoghourt can promote tear secretion, protect cornea and influence the expression of IL-6, TNF-alpha and IL-1beta in cornea tissues.

This utility model relates to the field of reagent kit technology and discloses a stackable reagent kit for detecting human lactose intolerance genes. The kit includes a first reagent kit, with a second reagent kit placed on top of the first kit. A plug is inserted into a socket, aligning the positioning posts with the positioning holes. The spring's restoring force pushes the two sets of positioning posts to slide and reset within guide grooves, allowing them to pass through the two sets of positioning holes. This achieves the purpose of stacking and connecting multiple reagent kits, facilitating the handling of multiple kits by medical personnel and preventing the kits from sliding and falling during transport, which could lead to reagent bottle leakage, environmental pollution, or even endanger the health and safety of testing personnel.

The invention belongs to the technical field of yoghurt, and discloses coconut yoghurt and a preparation method thereof, the coconut yoghurt comprises the following components by weight: 700 parts of purified water, 300 parts of coconut powder and probiotics. The structure is simple and reasonable, the coconut matrix avoids the milk protein allergy risk, and the coconut matrix is suitable for people with lactose intolerance and gluten sensitivity; lauric acid in coconuts accounts for more than 50%, so that energy is supplied quickly, fat is not easy to accumulate, and the coconut oil is suitable for body-building crowds; the coconut powder contains 7-8% of protein and potassium and magnesium elements, and supplements calcium together with the raw milk, the unsalted butter and the milk powder; according to the characteristics of low protein and high fiber of a coconut matrix, strains which are high in acid resistance and can decompose medium-chain fatty acid (MCFA) in coconut milk are screened, the acid production, aroma production and intestinal tract colonization capabilities are enhanced through multi-strain synergism, and 6-8% of fiber in coconut powder promotes proliferation of probiotics, so that double-effect synergy of'prebiotics and probiotics' is formed; the coconut yoghurt has both dairy product texture and tropical flavor, and fills the blank of thin taste of traditional soybean milk / almond milk yoghurt.

Provided are a lactobacillus reuteri VB319 and a culture apparatus and use therefor, relating to the field of microorganisms. The preservation number of the lactobacillus reuteri is CGMCC No.28158. The lactobacillus reuteri has the advantages of high lactose degradation rate, strong β-galactosidase activity, strong acid and alkali resistance, and strong cholate resistance etc., has strong antibacterial ability to common pathogenic bacteria, can be used for relieving lactose intolerance, regulating intestinal flora, and preventing and treating intestinal diseases caused by pathogenic bacteria infection. The application value is high. The lactobacillus reuteri VB319 culture apparatus can be used for batch producing fermentation products of the lactobacillus reuteri VB319, thereby facilitating the development of microbial agents, foods, medicines, health care products or feed production apparatuses. Commercial products can be produced in batches, and the economic value is high.

The present application relates to the field of animal nutrition and feed processing technology, and more particularly to a zero-lactose low-protein formula goat milk powder for animals and a preparation method thereof, the raw materials of the goat milk powder are fresh goat milk, compound enzymes and vitamins; the compound enzymes are composed of neutral lactase, compound protease and flavor enzyme at a mass ratio of 0.6-3:0.02-0.1:0.5-2.5. The present application successfully prepares a zero-lactose low-protein formula goat milk powder for animals with a lactose content of less than 0.22%, a protein content of about 12.5%, excellent fluidity and high stability in brewing by low-temperature long-time enzymolysis, synergistic effect of compound protease and flavor enzyme, embedding protection of flavor enzyme and microencapsulation of fat-soluble vitamins, eliminates the risk of lactose intolerance, reduces the protein allergenicity, optimizes the nutrient absorption and balance, and provides a more scientific feeding solution for sensitive or special-demand animals.